Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine post-session in acrophobia
NCT01102803Phase 3Completed
- Sponsor
- Southern Methodist University
- Start
- Apr 2010
- Primary completion
- Jul 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of d-cycloserine in acrophobia (2 arms), sponsored by Southern Methodist University. Primary endpoint: Acrophobia Questionnaire With Avoidance at 2 months. Started Apr 2010; status: completed.
02
Drugs
d-cycloserine
03
Conditions
acrophobia
Beyond the preview
Go deeper on NCT01102803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102803.